Weibel S L, Wolf H H
Pharmacol Biochem Behav. 1979 Jan;10(1):71-8. doi: 10.1016/0091-3057(79)90171-0.
Studies were conducted to confirm the involvement of central opiate receptors in the expression of opiate modulation of intracranial self-stimulation (ICSS). Biphasic, dose-related changes in ICSS responding are described following IP administration of morphine sulfate (1-25 mg/kg) and levorphanol tartrate (LEV, 0.5-5 mg/kg). Similar patterns of response modification are reported following intraventricular (IVt) administration of LEV (0.01-0.2 muMoles) LEV's enantiomorph, dextrorphan, was not found to elicit comparable effects after either IP or IVt administration. Both the facilitatory and the depressant phases of LEV's action were antagonized by naltrexone (10 microgram, IVt), which had no apparent effect on ICSS by itself. Complete tolerance developed to the suppression of responding by 2.5 mg/kg LEV (IP) but not to the facilitatory effect of 0.5 mg/kg (IP), during a 5-day course of administration. The implications of these results for opiate reinforcement theory are discussed and possible mechanisms are advanced.
开展了多项研究以证实中枢阿片受体与阿片类药物对颅内自我刺激(ICSS)调节作用的表达有关。静脉注射硫酸吗啡(1 - 25毫克/千克)和酒石酸左啡诺(LEV,0.5 - 5毫克/千克)后,ICSS反应呈现双相、剂量相关的变化。脑室内注射LEV(0.01 - 0.2微摩尔)后也报告了类似的反应改变模式。LEV的对映体右啡烷在静脉注射或脑室内注射后均未发现引发类似效应。LEV作用的兴奋期和抑制期均被纳曲酮(10微克,脑室内注射)拮抗,纳曲酮本身对ICSS无明显影响。在为期5天的给药过程中,对2.5毫克/千克LEV(静脉注射)引起的反应抑制产生了完全耐受性,但对0.5毫克/千克(静脉注射)的兴奋作用未产生耐受性。讨论了这些结果对阿片类药物强化理论的意义并提出了可能的机制。